Ensuring the safe use of biosimilars [PDF]
Ensuring the Safe Use of Biosimilars The arrival of biosimilars has sparked a debate as to whether the current INN system can guarantee their safe use.
Declerck, Paul
core
The Economic Value of Biosimilars
Biosimilars are biologic products that are similar to the reference biological product in physiochemical characteristics, pharmacokinetics, and efficacy and safety.
Simpson, Samantha
core +1 more source
Comparing prescribing and spending across originator, follow-on, and interchangeable biosimilar insulin glargine: Opportunities to improve uptake of biosimilar medications. [PDF]
Abrams LM, Funk K, Farley JF.
europepmc +1 more source
Effectiveness and Safety Outcomes After Switching from Reference Biologics to Biosimilars for Treatment of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis. [PDF]
Felfeli T +8 more
europepmc +1 more source
Biosimilars in diabetic macular edema: Promise, progress, and pitfalls. [PDF]
Jain V +4 more
europepmc +1 more source
Real-World Analysis of Switching Between Ranibizumab Biosimilars: Safety and Results - a Multicenter Retrospective Observational Study. [PDF]
Chakraborty D +7 more
europepmc +1 more source
Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience. [PDF]
D'Aquino MS, Amorim Filho RM, Amorim GM.
europepmc +1 more source
A landscape of sequence variants in 51 commercial antibody therapeutics. [PDF]
Xu G +8 more
europepmc +1 more source
Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy. [PDF]
Vitturi G +40 more
europepmc +1 more source
Understanding the market dynamics of biosimilars
Biosimilars represent an attractive market opportunity in the pharmaceutical industry. In order to understand the underlying market dynamics and to identify the success factors of the biosimilars market, a PEST (political, economic, social, technological)
Keßler, M. (Maximilian) +3 more
core

